Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Velos continues adding CTSA customers - 40% now use Velos products



FREMONT, Calif., June 30, 2015 /PRNewswire/ -- Velos, Inc., the pioneering software company for clinical research and specialty medicine, continues to grow and add customers who receive Clinical and Translational Science Awards ("CTSAs").  More than 40% of the 62 CTSAs awarded by the National Institutes of Health currently use Velos software for clinical research information management. This is among the largest such market shares in its product class. 

"Our presence in the CTSA community keeps growing as a result of our continued intense focus on the particular challenges and needs of this very important group of clinical researchers," says John S. McIlwain, President of Velos.

As clinical studies continue to increase in complexity, it is more challenging than ever to ensure that efficiency and compliance are being addressed and that patients are being treated in the most ethical manner possible. Velos helps research organizations address these issues through an integrated platform that enables management of the entire clinical research portfolio across multiple departments and sites, while also establishing a powerful foundation designed with industry standards, scalability and interoperability in mind. The return on investment is vast and varied, including faster study setup and turnaround time, improved accrual, increased regulatory compliance, more accurate and comprehensive research billing, reduced staff workloads, and higher data quality. Velos' solutions provide the CTSA community with a platform that creates an efficient and connected ecosystem and promotes administrative and scientific excellence while ensuring a strong, scalable and adaptable solution for their evolving needs.

Velos expects continued growth in the CTSA community through its flagship Velos eResearch product as well as Velos eResearch sister products for clinical research and translational medicine.  What's more, over the last several years the company has made major R&D investments to further extend the value and utility of its core clinical research product line. These innovations are scheduled to hit the market later in 2015 and beyond.

About Velos:

Velos is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the world. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California.

 

SOURCE Velos, Inc.


These press releases may also interest you

at 12:10
ISSAQUAH, Wash., Dec. 16, 2018 /PRNewswire-PRWeb/ -- University House Issaquah is one of only two retirement communities in King County, Washington on the Caring.com Caring Stars 2019 List. To earn the designation Caring.com considers consumer...

at 05:00
Leucan, the Association for children with cancer and their families, invites you to its Christmas Party to be held this Sunday, December 16, 2018, from 1:30 p.m. to 4 p.m., at Amiens Reception Halls in Saint-Léonard. Close to 75 families from the...

15 déc 2018
Industry is recalling certain cauliflower, red leaf lettuce and green leaf lettuce produced by Adam Bros. Farming Inc. of Santa Maria, California, United States (US) from the marketplace due to possible E. coli O157:H7 contamination. The affected...

15 déc 2018
As of the evening of December 15, $1,000,642 had been raised by the 16th Guignolée du Dr Julien fundraiser. This initial count includes only the funds raised for the Fondation's three centres of expertise and training and does not yet include the...

15 déc 2018
AutoNation, Inc. , America's largest automotive retailer, along with multi-platinum recording artist Andy Grammer, presented a check for $50,000 to the Breast Cancer Research Foundation (BCRF).  This money was raised through AutoNation and Andy...

15 déc 2018
The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on yesterday's court ruling in Texas v. United States: "AARP is deeply disappointed in yesterday's...




News published on 30 june 2015 at 18:26 and distributed by: